FARALLON CAPITAL MANAGEMENT LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 909661
SAN FRANCISCO, CA
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$778,248,897
+$109,074,205 QoQ
Shares Held
6,348,906
0.0% QoQ
Ownership
9.81%
of shares outstanding
% of Portfolio
4.59%
of 13F equity value
Holder Rank
#2
of 343 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FARALLON CAPITAL MANAGEMENT LLC holds $7,178,355,833 across 25 Biotechnology names. PTGX ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,670,881 | $2,537,793,074 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
10,743,063 | $800,143,332 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
This page
|
6,348,906 | $778,248,897 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,468,010 | $732,794,424 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
14,309,000 | $506,395,510 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
12,277,000 | $383,779,020 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,236,396 | $351,313,110 | |
| 8 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
8,989,098 | $336,372,047 |
All Filings in PTGX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $788,571,727 | 6,433,119 | Shares | Sole | 2026-08-13 | |
| 2026-06-30 | $778,248,897 | 6,348,906 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $669,174,692 | 6,348,906 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $536,617,484 | 6,144,006 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $411,600,678 | 6,196,006 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $341,126,771 | 6,172,006 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $295,334,810 | 6,107,006 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $228,898,231 | 5,930,006 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $263,745,270 | 5,861,006 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $202,382,784 | 5,840,773 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $166,028,488 | 5,738,973 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $131,490,479 | 5,734,430 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $90,846,452 | 5,446,430 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $124,605,696 | 4,511,430 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $60,145,322 | 2,615,014 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $39,842,087 | 3,651,887 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $30,785,407 | 3,651,887 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $29,271,809 | 3,700,608 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $26,863,941 | 1,134,457 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $65,565,982 | 1,917,134 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $42,386,240 | 2,392,000 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $104,556,038 | 2,329,680 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $62,807,500 | 2,425,000 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $48,888,000 | 2,425,000 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $53,762,500 | 2,750,000 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $44,150,000 | 2,500,000 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $10,590,000 | 1,500,000 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||